Transverse Myelitis Legal Battle: Essential Information
Two neurological conditions that share some similarities but have distinct differences are Multiple Sclerosis (MS) and Transverse Myelitis (TM).
Causes
MS is a chronic autoimmune disorder, where the immune system attacks the Central Nervous System (CNS) broadly, including the brain, spinal cord, and optic nerves, causing widespread demyelination and nerve damage over time [4]. On the other hand, TM is characterised by inflammation localised across both sides of a segment of the spinal cord, often triggered by autoimmune reactions, infections, or idiopathic reasons; it can sometimes be associated with MS but often occurs as a distinct condition [1][3].
Symptoms and Onset
MS symptoms usually develop gradually or episodically and include tingling, numbness, weakness, and sensory disturbances affecting various CNS areas like limbs, face, or other body parts. Symptoms may be diffuse due to multiple lesions in the CNS [4]. TM symptoms typically develop rapidly over hours to days and mainly manifest as sudden bilateral weakness, pain (often in the back), sensory changes below the affected spinal segment, and bowel or bladder dysfunction due to focal spinal cord inflammation [1][3].
Effects on the CNS
MS causes scattered patches of demyelination affecting multiple CNS regions (brain and spinal cord), leading to variable and progressive neurological deficits [4]. TM involves acute inflammation and demyelination limited mainly to a transverse section of the spinal cord, causing symptoms restricted to spinal cord functions—motor, sensory, and autonomic functions below the lesion level [1][3].
Overlap
TM can be a presenting feature or complication of MS, reflecting their shared mechanism of immune-mediated CNS inflammation and demyelination [3][5]. However, TM can also occur independently without MS.
Diagnosis and Treatment
For both MS and TM, MRI imaging, lumbar puncture with spinal fluid analysis, evoked potential tests, CT scans, and blood tests are used to diagnose the conditions [2].
While TM is usually treated with intravenous corticosteroid drugs, plasma exchange therapy, and antibody therapy called intravenous immunoglobulin, MS treatment varies and includes a range of disease-modifying treatments and IV corticosteroid drugs [1][3][6].
Risk Factors
Some genes can increase a person's risk of developing MS, and the Epstein-Barr virus (EBV) can potentially increase MS risk due to a person's immune response to the virus, not necessarily the virus itself [7][8]. Smoking is also a risk factor for developing MS [9]. The Toxoplasma gondii parasite can increase the risk of TM [10]. Vitamin D deficiency is a risk factor for developing MS [11].
Distinct Symptoms
Vision problems are a common and often an early symptom of MS, but not of TM. The term multiple sclerosis means "scar tissue in multiple areas," and MS occurs when the immune system attacks the myelin sheath that surrounds and protects nerve fibers [12]. Transverse myelitis damages the myelin covering the nerves in the spine over time.
In summary, MS is a chronic CNS disease affecting multiple sites including brain and spinal cord with a variety of neurological symptoms developing over time, whereas TM is usually an acute or subacute inflammatory spinal cord syndrome with localized symptoms and a narrower anatomical impact within the CNS. Both involve immune-driven myelin damage but differ in distribution, progression, and symptom patterns.
Read also:
- Abu Dhabi initiative for comprehensive genetic screening, aiming to diagnose over 800 conditions and enhance the health of future generations in the UAE.
- Elderly shingles: Recognizing symptoms, potential problems, and available treatments
- Protecting Your Auditory Health: 6 Strategies to Minimize Noise Damage
- Exploring the Reasons, Purposes, and Enigmas of Hiccups: Delving into Their Origins, Roles, and Unsolved Aspects
